[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Compass Pathways Plc ADR (CMPS)

Compass Pathways Plc ADR (CMPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,840,705
  • Shares Outstanding, K 134,949
  • Annual Sales, $ 0 K
  • Annual Income, $ -287,860 K
  • EBIT $ -172 M
  • EBITDA $ -172 M
  • 60-Month Beta 2.47
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.37

Options Overview Details

View History
  • Implied Volatility 108.05% (+6.83%)
  • Historical Volatility 77.64%
  • IV Percentile 53%
  • IV Rank 22.86%
  • IV High 232.72% on 02/10/26
  • IV Low 71.12% on 05/14/26
  • Expected Move (DTE 5) 1.06 (7.79%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 11,459
  • Volume Avg (30-Day) 5,005
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 134,087
  • Open Int (30-Day) 123,537
  • Expected Range 12.58 to 14.70

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.46
  • Number of Estimates 6
  • High Estimate $-0.31
  • Low Estimate $-0.70
  • Prior Year $-0.38
  • Growth Rate Est. (year over year) -21.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.72 +27.19%
on 06/11/26
15.40 -11.43%
on 06/29/26
+2.61 (+23.66%)
since 06/10/26
3-Month
5.54 +146.21%
on 04/13/26
15.40 -11.43%
on 06/29/26
+8.11 (+146.65%)
since 04/10/26
52-Week
3.45 +295.36%
on 07/14/25
15.40 -11.43%
on 06/29/26
+9.92 (+266.67%)
since 07/10/25

Most Recent Stories

More News
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile

New 6-month data supports COMP360’s potential to establish a new standard of care in TRD Data from positive COMP006 Phase 3 trial demonstrates durable...

CMPS : 13.64 (+0.29%)
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under...

CMPS : 13.64 (+0.29%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END

HELP : 6.87 (+3.62%)
CMPS : 13.64 (+0.29%)
GHRS : 26.51 (-2.54%)
JNJ : 256.98 (-0.82%)
DFTX : 47.07 (-2.85%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients...

HELP : 6.87 (+3.62%)
CMPS : 13.64 (+0.29%)
GHRS : 26.51 (-2.54%)
JNJ : 256.98 (-0.82%)
DFTX : 47.07 (-2.85%)
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer

WALTHAM, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced the appointment...

CMPS : 13.64 (+0.29%)
KLRA : 20.68 (-1.57%)
SPRO : 2.10 (-0.94%)
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under...

CMPS : 13.64 (+0.29%)
Compass Pathways Elects Kathleen Tregoning to Board of Directors

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning to...

CMPS : 13.64 (+0.29%)
SPRO : 2.10 (-0.94%)
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies...

CMPS : 13.64 (+0.29%)
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins

Compass Pathways (NASDAQ:CMPS) executives said the company remains on track to target a fourth-quarter New Drug Application filing for COMP360, its synthetic psilocybin treatment candidate for treatment-resistant...

CMPS : 13.64 (+0.29%)
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the RBC...

CMPS : 13.64 (+0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK.

See More

Key Turning Points

3rd Resistance Point 15.11
2nd Resistance Point 14.56
1st Resistance Point 14.10
Last Price 13.64
1st Support Level 13.09
2nd Support Level 12.54
3rd Support Level 12.08

See More

52-Week High 15.40
Last Price 13.64
Fibonacci 61.8% 10.84
Fibonacci 50% 9.43
Fibonacci 38.2% 8.01
52-Week Low 3.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.